demonstrate that coverage matches the scope of the trial (population, geography, intervention, and risk level).

HRA and Ethics Committees

RECs review insurance documents during the ethics approval process. They verify that insurance certificates explicitly cover the clinical trial and that compensation schemes are compliant with UK ethical standards.

Core Clinical Trial Insights — Step-by-Step Process

Step 1 — Identify Insurance Obligations

Sponsors must secure adequate insurance before submitting a CTA. This may include commercial clinical trial insurance or NHS indemnity, depending on the trial sponsor type.

Step 2 — Choose the Right Type of Coverage

Common types of UK trial insurance include:

• Commercial Insurance: Purchased by sponsors/CROs to cover trial liabilities.
• NHS Indemnity: Covers NHS-employed investigators when trials are conducted within NHS Trusts.
• Hybrid Policies: Combining sponsor-purchased insurance with NHS coverage for investigators.

Step 3 — Prepare Insurance Documentation

Insurance certificates must:

• Explicitly reference the clinical trial
• Include policy number, coverage limits, and effective dates
• Be valid for the entire duration of the trial
• Cover all participating trial sites

Step 4 — Submit Insurance Details with IRAS Application

When applying through IRAS, sponsors must upload insurance certificates as part of the CTA and REC submission. HRA/RECs review them for adequacy.

Step 5 — Address Investigator Indemnity

Investigators working within the NHS are covered under NHS indemnity for negligence claims. Independent investigators may need separate indemnity insurance.

Step 6 — Maintain Compliance During the Trial

Sponsors must ensure insurance remains active for the trial duration. Renewals must be managed proactively, and updated certificates should be filed in the Trial Master File (TMF).

Step 7 — Prepare for MHRA Inspection

MHRA inspections often flag:

• Lapsed or expired insurance policies
• Coverage that excludes trial-specific activities
• Failure to provide certificates during inspection
• Poor oversight of CRO-managed insurance policies

Best Practices & Preventive Measures

• Secure insurance early, before trial submission.
• Confirm policies explicitly mention the trial protocol title/identifier.
• Document insurance in the TMF and ensure sites hold copies.
• Train trial teams on insurance scope and participant rights.
• Audit CRO insurance arrangements to confirm compliance.

Scientific and Regulatory Evidence

• Medicines for Human Use (Clinical Trials) Regulations 2004 (as amended)
• MHRA Clinical Trials Guidance on Insurance and Indemnity
• HRA Ethics Review Insurance Standards
• NHS Indemnity Policies
• ICH E6(R2) Good Clinical Practice

Special Considerations

• Pediatric Trials: Higher risk sensitivity requires explicit insurance confirmation for child participants.
• Rare Diseases: Long trial durations demand insurance policies covering extended timeframes.
• Advanced Therapies: ATMP trials often require higher coverage limits due to long-term risks.
• Multinational Trials: Sponsors must align UK insurance with global insurance arrangements.

When Sponsors Should Seek Regulatory Advice

• When uncertain if NHS indemnity alone is sufficient.
• If trial design involves novel therapies with high liability risk.
• For multinational trials requiring harmonised insurance across jurisdictions.
• When CROs manage insurance policies on behalf of sponsors.
• If MHRA or RECs flag deficiencies in submitted certificates.

FAQs

1. Is insurance mandatory for all UK clinical trials?

Yes. Adequate insurance or indemnity must be in place before a trial can begin.

2. What types of insurance are acceptable?

Commercial clinical trial insurance, NHS indemnity, or hybrid coverage depending on the sponsor and trial structure.

3. Who reviews insurance during approvals?

HRA/RECs review insurance certificates for adequacy, and MHRA checks them during inspections.

4. Are investigators covered under NHS indemnity?

Yes, if they are NHS employees. Independent investigators may require separate indemnity insurance.

5. What happens if insurance lapses mid-trial?

It constitutes non-compliance. MHRA may suspend the trial until valid insurance is restored.

6. Do insurance requirements differ for pediatric trials?

Yes, insurers often require explicit mention of pediatric populations and may set higher premiums.

7. How do sponsors prove insurance coverage?

By providing valid insurance certificates that reference the trial, coverage limits, and effective dates.

Conclusion

Insurance in UK clinical trials is a non-negotiable regulatory requirement. Sponsors, investigators, and NHS Trusts must demonstrate adequate coverage to protect participants and ensure compliance. By following a step-by-step approach—securing coverage early, maintaining valid certificates, and preparing for REC/MHRA scrutiny—sponsors can avoid regulatory delays and ensure trials proceed smoothly while safeguarding patient welfare.